Icecure Medical is trading at $1.67, up +5.03% after-hours; no clear company-specific announcement explaining the rise was found. - The latest identified company news was China regulatory approval announced September 10. - Broader indexes were mixed, and available evidence does not establish a market-wide catalyst. - Shares traded between $1.59 and $1.69 during September 29’s regular session.